Research News & Funding Opportunities for Tulane Cancer Researchers - July 23, 2024 | |
Tulane Cancer Center Member to Co-Lead COBRE in Sex-Based Medicine | |
Tulane Cancer Center Member and Director of Tulane's Center of Excellence in Sex-Based Biology & Medicine Franck Mauvais-Jarvis, MD, PhD, (right) and M.A. "Tonette" Krousel-Wood, MD, MSPH, director of the Center for Health Outcomes, Implementation and Community Engaged Sciences (CHOICES), will lead Tulane's new Center of Biological Research Excellence in Sex-Based Medicine, established with the award of an $11.2 million grant from the National Institutes of Health. The center will explore the differences between biological sexes and genders, investigate how those differences can impact medical outcomes, and potentially help shape specialized treatments. Read more on the Tulane News website. | |
|
American Cancer Society Webinars & Courses
Pediatric, Adolescent, and Young Adult Cancer Survivorship ECHO
The ECHO series on Pediatric, Adolescent, and Young Adult Cancer Survivorship is a 12-month educational program starting on July 24, 2024. The ECHO includes monthly virtual sessions for health care providers caring for post-treatment cancer survivors diagnosed before age 40 years. CME credits are available. REGISTER HERE
ACS LION/ASCO Patient Navigation Webinar - July 29, 2 - 3 PM CDT
This joint webinar between ACS and ASCO will cover the ASCO Certified Patient-Centered Cancer Care Standards, as well as innovative models and best practices to build high quality, sustainable, navigation services. REGISTER HERE
American College of Sports Medicine (ACSM)-ACS Cancer Exercise Specialist Certificate Course
ACS has partnered with the ACSM to offer the ACSM-ACS Cancer Exercise Specialist certificate course. For the month of July 2024, ACS partners receive a 20% discount on the course using the code ACSPARTNER. Click here for more information.
|
|
|
Emma Bates
Tulane Cancer Center Mentor:
Jennifer Fang, PhD
Project: Investigating ways to increase the production of certain key proteins in blood vessel cells to determine whether an uncontrolled increase causes the cells to grow too many new blood vessels
| |  |
|
Jack Erickson-King
Tulane Cancer Center Mentor:
Matthew Burow, PhD
Project: Investigating phytochemicals produced by plants in response to stress and their ability to subdue breast cancer proliferation
| | |
|
Giancarlo Lara
Tulane Cancer Center Mentor:
Zhen Lin, MD, PhD
Project: Investigating the role of a novel type of non-coding RNA in the development of Epstein-Barr virus-associated cancers
| | |
|
Rashmi Srivastava
Tulane Cancer Center Mentor:
Hua Lu, MB, PhD
Project: Exploring the molecular and biochemical mechanisms of cell proliferation and tumorigenesis, focusing on the p53 and c-Myc pathways.
| | |
|
DELTA INNOVATOR SEARCH SEEKING NEW IDEAS TO IMPROVE HEALTH, ECONOMY IN REGION
Researchers, students, entrepreneurs, and innovators with ideas for advancing the health and economy of the Delta region of Arkansas, Mississippi, and Louisiana are encouraged to enter the inaugural Delta Innovator Search.
Projects should align with at least one of three target categories:
Scientific or Technical Innovations
Economic or Financial Innovations
Community Impact 2040
Applicant Eligibility
Individuals, nonprofits, small businesses, entrepreneurs, students, faculty, cooperatives, teams, or other groups and entities with new ideas or solutions that could make the Delta a healthier, economically thriving region are encouraged to apply.
Applicants must be at least 18 years old and residents of Arkansas, Mississippi, or Louisiana OR demonstrate authentic partnership with an organization from the area that serves residents.
Deadline to Apply: July 30, 2024
| |
|
Tulane Cancer Center now has an institutional subscription to The Cancer Letter, an independent weekly newsletter that is the leading source of information on:
- National Cancer Institute
- National Institutes of Health
- Food & Drug Administration
- the development of cancer therapies
- cancer research funding
- health care finance
- cancer legislation and policy
- clinical issues
- the pharmaceutical industry
Our institutional subscription allows anyone with a Tulane IP address to be automatically logged in when visiting www.cancerletter.com. From there you can view current and previous issues of the publication, with no need to create an individual account.
For more information, please click here.
|
|
|
The American Cancer Society recently launched several new online resources and tools designed to support medical professionals, cancer patients, caregivers, and survivors in their journey.
This flier provides links to a variety of evidence-based, understandable and actionable resources to help healthcare teams educate and empower their patients and caregivers. For more information, visit cancer.org.
| |
|
American Society of Hematology (ASH) Annual Meeting - ABSTRACT SUBMISSION DEADLINE
This is a reminder that the abstract submission deadline for the ASH Annual Meeting, taking place December 7 - 10, 2024, in San Diego is Thursday, August 1.
For more information and key dates for ASH 2024, click HERE.
|
|
To register for this workshop, please click here.
| |
Support Fund FY 2024-25 Competitions Now Available
Requests for Proposals (RFPs) for Board of Regents Support Fund FY 2024-25 competitions are now available on the BOR website, http://web.laregents.org.
The below documents set forth all requirements for submission of proposals.
BOR Opportunities & Deadlines
BOR Notice of Intent & Proposal Submission Dates
Across all programs, the BoRSF seeks projects that, if funded, are likely to have clearly defined, significant benefits for Louisiana higher education and economic development. It is critical that applicants carefully read RFPs in their entirety to understand the types of projects and requirements.
Please note: The RFP requires a documented institutional screening process for Departmental Enhancement Proposals only. Departmental Enhancement Proposals MAY NOT BE SUBMITTED WITHOUT DOCUMENTATION OF INSTITUTIONAL REVIEW AND RANKING. To facilitate the review process, submission of a pre-proposal is required, to include this document, along with a CV/Biosketch. The required documents must be emailed as one pdf to Sponsored Projects Administration at dlovrov@tulane.edu no later than September 5, 2024.
| |
Damon Runyon Fellowship Award
The Damon Runyon Cancer Research Foundation is a leading nonprofit organization that funds brave and bold cancer researchers. Damon Runyon’s mission is to identify and support the best early career scientists pursuing innovative research that has the potential to transform cancer prevention, diagnosis, and treatment. Their goal is to encourage new generations of outstanding researchers to pursue paradigm-shifting ideas and approaches as they begin highly productive, successful research careers.
Damon Runyon views cancer research very broadly, including the full spectrum of basic questions important to normal human biology and carcinogenesis, as well as development of new platforms and technologies. They encourage all theoretical and experimental research that has the potential to provide insights into cancer and the search for cancer causes, mechanisms, therapies, and prevention for all types of cancer.
They are now accepting applications for the prestigious Damon Runyon Fellowship Award.
APPLICATION DEADLINE: August 15, 2024
The primary criteria used to evaluate applicants are:
- the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques, and clarity of presentation),
- the qualifications, experience, and productivity of both the candidate and the Sponsor,
- the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand their scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded.
Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO.
This four-year award provides $70,000, $72,000, $74,000, and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. The award may not be used for institutional overhead or indirect costs.
To learn more about the Foundation and the Fellowship Award review process, view the virtual Fellowship Informational Session here.
| |
|
Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award
The Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis, or treatment of one or more pediatric cancers.
Applicants are not required to be pediatricians or members of pediatric departments; however, the proposed research must have direct relevance to one or more pediatric cancers.
Application Guidelines
APPLICATION DEADLINE: August 15, 2024
The primary criteria used to evaluate applicants are:
- potential impact of the research on pediatric cancer
- the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques, and clarity of presentation)
- the qualifications, experience, and productivity of both the candidate and the sponsor
- the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand their scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded.
Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO.
This four-year award provides $70,000, $72,000, $74,000, and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. Damon Runyon also provides a Dependent Child Allowance of $1,000 per child per year. The award may not be used for institutional overhead or indirect costs.
| |
Pfizer Global Medical Grants Announces a New Education RFP in Cervical Cancer
Improving Care for Patients with Recurrent / Metastatic (R/M) Cervical Cancer
The goal of this RFP is to support education for medical oncologists, gynecologic oncologists, pharmacists, eye care providers, nurse practitioners and physician assistants working in the oncology setting caring for patients with r/m cervical cancer relating to treatments, management of adverse events, and long-term outcomes.
To review the full RFP please click here.
Application Due Date: August 22, 2024
Tony Enterante, Senior Development Officer for Corporate, Foundation and Research Relations, is happy to work with applicants on their submissions. You can contact Tony at aenteranteiii@tulane.edu.
| |
Robert L. Fine Cancer Research Foundation Pancreatic Cancer Research Grant
Application Deadline: August 31, 2024
The Robert L. Fine Cancer Research Foundation distributes two awards every other year to outstanding young scientists dedicated to basic and translational pancreatic cancer research. The grant is intended to support research projects that can be carried out in a short period of time with limited resources. The topic of the requested grant applications will be for innovative translational pancreatic cancer research that focuses on bench to bedside advances. The grant mechanism supports different types of basic and translational projects, including pilot and feasibility studies, self-contained research projects, development of new research methodology and development of new research technology. This grant does not support solely clinical research.
The grant amount will be $250,000 to cover direct costs only. The length of the grant will be for two years payable in yearly installments. Pre-award costs are allowable, up to 30 days prior to the grant initiation date; however, the incurrence of pre-award costs imposes no obligation on the foundation to grant the award. Funding for awardees will start January 1, 2025.
For more information, click here.
| |
Request for Proposals
Equity in Access Research Program
The Leukemia & Lymphoma Society (LLS) has just released a Request for Proposals (RFP) for its Equity in Access Research Program, which is dedicated to funding health services research.
They are reissuing the RFP Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.
Specifically, they seek proposals that will implement and evaluate interventions designed to:
- Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
- Quantitatively measure the impact of these interventions on patient accrual
They are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.
It is not necessary for applicants to have previously conducted research in blood cancer. The due date for Letters of Intent is September 12, 2024 at 2 pm CST.
For more information, please click here.
| |
2025 Macy Faculty Scholars Program
Call for Applications
Application Deadline: September 15
The 2025 Macy Faculty Scholars Program aims to identify and nurture promising early-career educators in medicine and nursing. Macy Faculty Scholars receive up to $250,000 of salary, project, and professional development support over two years to implement an educational project in their home institutions.
Visit the website to learn more about the program and get started on your application.
| |
Recent Member Publications | |
|
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation. Kean LS, Burns LJ, Kou TD, Kapikian R, Lozenski K, Langston A, Horan JT, Watkins B, Qayed M, Bratrude B, Betz K, Tang XY, Zhang MJ, Connolly SE, Polinsky MS, Gavin BJ, Gomez-Caminero A, Pasquini MC. Blood. 2024 Jul 19:blood.2023023660. doi: 10.1182/blood.2023023660. Online ahead of print. PMID: 39028876
Understanding Intensive Care Unit Family Caregivers' Vulnerability to Post-Traumatic Stress Disorder: The Impact of Neurotic Personality Traits, Emotional Suppression, and Perceptions of Unexpected Death.
Gerhart J, Bruins G, Hoerger M, Boehm LM, White K, Brugh C, Greenberg JA. J Palliat Med. 2024 Jul 18. doi:10.1089/jpm.2023.0689. Online ahead of print. PMID: 39023049
C/EBPβ deletion in macrophages impairs mammary gland alveolar budding during the estrous cycle. Rojo MD, Bandyopadhyay I, Burke CM, Sturtz AD, Phillips ES, Matherne MG, Embrey SJ, LaRue R, Qiu Y, Schwertfeger KL, Machado HL. Life Sci Alliance. 2024 Jul 18;7(10):e202302516. doi: 10.26508/lsa.202302516. Print 2024 Oct. PMID: 39025525
| |
Connect with Us on Social Media | |
Please visit Tulane Cancer Center on Facebook, Instagram and LinkedIn and follow us for all the latest news in cancer research, education and patient care.
You can access our profile pages by clicking on the icons below.
| |
Acknowledging Tulane Cancer Center Support in Publications
One of the responsibilities of membership in the Tulane Cancer Center is acknowledgement of Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in presentations and publications
We suggest using the following wording when acknowledging Tulane Cancer Center support: "This work was supported by the Tulane Cancer Center, part of Tulane Medical School and a consortium partner of the Louisiana Cancer Research Center."
| |
Tulane Cancer Center Branded Assets
Tulane Cancer Center has recently undertaken a brand refresh that not only streamlines and modernizes the look and feel of our brand but also aligns us more closely with the School of Medicine branding.
With that in mind, we have developed a full suite of branded assets for your immediate use, including:
- A Tulane Cancer Center-branded PowerPoint Slide Master
- A Tulane Cancer Center-branded Scientific Poster Template (sized at 4 feet x 3 feet)
- Tulane Cancer Center-branded Zoom Backgrounds
- Tulane Cancer Center’s updated logo
- Tulane Cancer Center-branded Email Signature Blocks
All Tulane Cancer Center Members should have received these files via a recent listserv email. If you did not receive the email but would like to begin using these templates, please contact Melanie Cross at mcross@tulane.edu.
Please also continue to acknowledgement your Tulane Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in all presentations and publications.
Thank you for your assistance in helping us to expand our visibility while showcasing the depth and breadth of our outstanding basic, translational and population science research and clinical care.
| |
|
The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.
More Information
| |
Cell Analysis Core
The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.
More Information
| |
Tulane Cancer Center & LCRC Membership
Any Tulane University faculty member whose research relates to or could potentially relate to cancer – directly or indirectly – should become a member of the Tulane Cancer Center (TCC). As a member, you have access to TCC's funding opportunities, research collaboration events, and shared resources. Please click here for our membership guidelines and our online application form.
Cancer-focused faculty are also encouraged to become members of the Louisiana Cancer Research Center, a partnership between the State's foremost cancer research institutions - Tulane University School of Medicine, LSU Health Sciences Center New Orleans, Xavier University of Louisiana and Ochsner Health. Membership in the LCRC provides access to additional funding opportunities exclusively offered to LCRC members. Please click here for the LCRC's membership guidelines and online application form.
| |
Subscribe to Nexus
If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.
| |
Send Us Your News / Share Your Feedback | |
Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.
| | | | |
